User Visitor Login
English only
EPFL > FSV > BBP > Channelpedia
Ion channels
Logged in as a Visitor.

All references automaticaly matched for Cav3.3

102. Pubmed Yang W. et al. Cannabinoid receptor agonists modulate calcium channels in rat retinal müller cells. Neuroscience, 2016 Jan 28 , 313 (213-24).
101. Pubmed Elíes J. et al. Regulation of the T-type Ca(2+) channel Cav3.2 by hydrogen sulfide: Emerging controversies concerning the role of H2 S in nociception. J. Physiol. (Lond.), 2016 Jan 25 , ().
100. Pubmed Kumar D. et al. Cacna1c (Cav1.2) Modulates Electroencephalographic Rhythm and Rapid Eye Movement Sleep Recovery. Sleep, 2015 Sep , 38 (1371-80).
99. Pubmed Harraz O. et al. CaV1.2/CaV3.x channels mediate divergent vasomotor responses in human cerebral arteries. J. Gen. Physiol., 2015 May , 145 (405-18).
98. Pubmed Monteil A. et al. Inhibition of Cav3.2 T-type Calcium Channels by Its Intracellular I-II Loop. J. Biol. Chem., 2015 Jun 26 , 290 (16168-76).
97. Pubmed Elíes J. et al. H2S does not regulate proliferation via T-type Ca2+ channels. Biochem. Biophys. Res. Commun., 2015 Jun 12 , 461 (659-64).
96. Pubmed Tompkins J. et al. Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability. Am. J. Physiol., Cell Physiol., 2015 Jun 1 , 308 (C857-66).
95. Pubmed Wang Q. et al. [Effects of bisphenol A on voltage-dependent T-type calcium channels in mouse testis and epididymis, and the role of estrogen receptors]. Wei Sheng Yan Jiu, 2015 Jan , 44 (23-7).
94. Pubmed Reynders A. et al. Transcriptional Profiling of Cutaneous MRGPRD Free Nerve Endings and C-LTMRs. Cell Rep, 2015 Feb 12 , ().
93. Pubmed Basson M. et al. Increased extracellular pressure stimulates tumor proliferation by a mechanosensitive calcium channel and PKC-β. Mol Oncol, 2015 Feb , 9 (513-26).
92. Pubmed Fukunaga K. et al. [Cognitive Function and Calcium. Cognitive improvement through T type calcium channel stimulation]. Clin Calcium, 2015 Feb , 25 (247-54).
91. Pubmed Tomasova L. et al. Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channels. Nitric Oxide, 2015 Apr 30 , 46 (131-44).
90. Pubmed Staehlke S. et al. Intracellular calcium dynamics dependent on defined microtopographical features of titanium. Biomaterials, 2015 Apr , 46 (48-57).
89. Pubmed Elíes J. et al. Inhibition of T-type Ca(2+) Channels by Hydrogen Sulfide. Adv. Exp. Med. Biol., 2015 , 860 (353-60).
88. Pubmed Calderón-Rivera A. et al. Regulation of neuronal cav3.1 channels by cyclin-dependent kinase 5 (Cdk5). PLoS ONE, 2015 , 10 (e0119134).
87. Pubmed Wang C. et al. Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients. PLoS ONE, 2015 , 10 (e0125766).
86. Pubmed Watanabe M. et al. Expression and Regulation of Cav3.2 T-Type Calcium Channels during Inflammatory Hyperalgesia in Mouse Dorsal Root Ganglion Neurons. PLoS ONE, 2015 , 10 (e0127572).
85. Pubmed Cazade M. et al. 5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone. Pflugers Arch., 2014 Sep , 466 (1759-68).
84. Pubmed Fekete A. et al. Presynaptic T-type Ca2+ channels modulate dendrodendritic mitral-mitral and mitral-periglomerular connections in mouse olfactory bulb. J. Neurosci., 2014 Oct 15 , 34 (14032-45).
83. Pubmed González-Ramírez R. et al. Transcription factor Sp1 regulates T-type Ca(2+) channel CaV 3.1 gene expression. J. Cell. Physiol., 2014 May , 229 (551-60).
82. Pubmed Cui Y. et al. Exposure to extremely low-frequency electromagnetic fields inhibits T-type calcium channels via AA/LTE4 signaling pathway. Cell Calcium, 2014 Jan , 55 (48-58).
81. Pubmed Cazade M. et al. Cross-Modulation and Molecular Interaction at the Cav3.3 Protein between the Endogenous Lipids and the T-Type Calcium Channel Antagonist TTA-A2. Mol. Pharmacol., 2014 Feb , 85 (218-25).
80. Pubmed Michaela P. et al. Bisphenol A differently inhibits CaV3.1, Ca V3.2 and Ca V3.3 calcium channels. Naunyn Schmiedebergs Arch. Pharmacol., 2014 Feb , 387 (153-63).
79. Pubmed Elíes J. et al. Hydrogen sulfide inhibits Cav3.2 T-type Ca2+ channels. FASEB J., 2014 Dec , 28 (5376-87).
78. Pubmed Lee S. et al. Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice. Proc. Natl. Acad. Sci. U.S.A., 2014 Aug 12 , 111 (11828-33).
77. Pubmed Dufour M. et al. Somatodendritic ion channel expression in substantia nigra pars compacta dopaminergic neurons across postnatal development. J. Neurosci. Res., 2014 Aug , 92 (981-99).
76. Pubmed Chemin J. et al. Modulation of T-type calcium channels by bioactive lipids. Pflugers Arch., 2014 Apr , 466 (689-700).
75. Pubmed Shuba Y. et al. Models of calcium permeation through T-type channels. Pflugers Arch., 2014 Apr , 466 (635-44).
74. Pubmed Gangarossa G. et al. T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants. Front Behav Neurosci, 2014 , 8 (92).
73. Pubmed Bladen C. et al. Block of T-type calcium channels by protoxins I and II. Mol Brain, 2014 , 7 (36).
72. Pubmed Elies J. et al. OP20 Inhibition of recombinant T-type Ca(2+) channels by hydrogen sulfide. Nitric Oxide, 2013 Sep 1 , 31 Suppl 2 (S27-8).
71. Pubmed Seo H. et al. Effects of eugenol on T-type Ca2+ channel isoforms. J. Pharmacol. Exp. Ther., 2013 Nov , 347 (310-7).
70. Pubmed Gouriou Y. et al. Mitochondrial Ca2+ uptake from plasma membrane Cav3.2 protein channels contributes to ischemic toxicity in PC12 cells. J. Biol. Chem., 2013 May 3 , 288 (12459-68).
69. Pubmed Yue J. et al. Upregulation of T-type Ca2+ channels in primary sensory neurons in spinal nerve injury. Spine, 2013 Mar 15 , 38 (463-70).
68. Pubmed Albéri L. et al. The calcium-binding protein parvalbumin modulates the firing 1 properties of the reticular thalamic nucleus bursting neurons. J. Neurophysiol., 2013 Jun , 109 (2827-41).
67. Pubmed Zhang Y. et al. Modulation of low-voltage-activated T-type Ca²⁺ channels. Biochim. Biophys. Acta, 2013 Jul , 1828 (1550-9).
66. Pubmed Astori S. et al. Synaptic plasticity at intrathalamic connections via CaV3.3 T-type Ca2+ channels and GluN2B-containing NMDA receptors. J. Neurosci., 2013 Jan 9 , 33 (624-30).
65. Pubmed Boycott H. et al. Carbon monoxide inhibition of Cav3.2 T-type Ca2+ channels reveals tonic modulation by thioredoxin. FASEB J., 2013 Aug , 27 (3395-407).
64. Pubmed Shan H. et al. Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. Alcohol. Clin. Exp. Res., 2013 Aug , 37 (1333-42).
63. Pubmed Waszkielewicz A. et al. Ion channels as drug targets in central nervous system disorders. Curr. Med. Chem., 2013 , 20 (1241-85).
62. Pubmed Sekiguchi F. et al. T-type calcium channels: functional regulation and implication in pain signaling. J. Pharmacol. Sci., 2013 , 122 (244-50).
61. Pubmed Brennan S. et al. Fetal calcium regulates branching morphogenesis in the developing human and mouse lung: involvement of voltage-gated calcium channels. PLoS ONE, 2013 , 8 (e80294).
60. Pubmed Wimmer R. et al. Sustaining sleep spindles through enhanced SK2-channel activity consolidates sleep and elevates arousal threshold. J. Neurosci., 2012 Oct 3 , 32 (13917-28).
59. Pubmed Lopez-Charcas O. et al. Block of human CaV3 channels by the diuretic amiloride. Mol. Pharmacol., 2012 Oct , 82 (658-67).
58. Pubmed Kirkton R. et al. Genetic engineering of somatic cells to study and improve cardiac function. Europace, 2012 Nov , 14 Suppl 5 (v40-v49).
57. Pubmed Chevalier M. et al. Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels. , 2012 Mar 3 , ().
56. Pubmed Balderas E. et al. Niflumic acid blocks native and recombinant T-type channels. J. Cell. Physiol., 2012 Jun , 227 (2542-55).
55. Pubmed Li C. et al. [Distribution diversity of integrins and calcium channels on major human and mouse host cells of Leptospira species]. Zhejiang Da Xue Xue Bao Yi Xue Ban, 2012 Jul , 41 (410-7).
54. Pubmed Zhang Y. et al. Inhibition of T-type Ca(2+) channels by endostatin attenuates human glioblastoma cell proliferation and migration. , 2012 Jan 10 , ().
53. Pubmed Kolaj M. et al. Midline thalamic paraventricular nucleus neurons display diurnal variation in resting membrane potentials, conductances, and firing patterns in vitro. J. Neurophysiol., 2012 Apr , 107 (1835-44).
52. Pubmed Li Y. et al. β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. PLoS ONE, 2012 , 7 (e39965).
51. Pubmed Matsunami M. et al. Chelating luminal zinc mimics hydrogen sulfide-evoked colonic pain in mice: possible involvement of T-type calcium channels. Neuroscience, 2011 May 5 , 181 (257-64).
50. Pubmed Hazra R. et al. A transcriptomic analysis of type I-III neurons in the bed nucleus of the stria terminalis. , 2011 Feb 7 , ().
49. Pubmed Yalçın O. et al. Genes and molecular mechanisms involved in the epileptogenesis of idiopathic absence epilepsies. , 2011 Dec 27 , ().
48. Pubmed Lacinová L. et al. T-type calcium channel blockers - new and notable. Gen. Physiol. Biophys., 2011 Dec , 30 (403-9).
47. Pubmed Brunner J. et al. Pharmacological validation of candidate causal sleep genes identified in an N2 cross. J. Neurogenet., 2011 Dec , 25 (167-81).
46. Pubmed Astori S. et al. The Ca(V)3.3 calcium channel is the major sleep spindle pacemaker in thalamus. Proc. Natl. Acad. Sci. U.S.A., 2011 Aug 16 , 108 (13823-8).
45. Pubmed Lei D. et al. Anti-epileptic drugs delay age-related loss of spiral ganglion neurons via T-type calcium channel. Hear. Res., 2011 Aug , 278 (106-12).
44. Pubmed Chen W. et al. Complex distribution patterns of voltage-gated calcium channel α-subunits in the spiral ganglion. Hear. Res., 2011 Aug , 278 (52-68).
43. Pubmed Karmazinova M. et al. The voltage dependence of gating currents of the neuronal CA(v)3.3 channel is determined by the gating brake in the I-II loop. Pflugers Arch., 2011 Apr , 461 (461-8).
42. Pubmed Wang Q. et al. Effects of raloxifene on voltage-dependent T-type Ca2+ channels in mouse spermatogenic cells. Pharmacology, 2011 , 87 (70-80).
41. Pubmed David L. et al. Splice-variant changes of the Ca(V)3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development. Channels (Austin), 2010 Sep-Oct , 4 (375-89).
40. Pubmed Cain S. et al. Contributions of T-type calcium channel isoforms to neuronal firing. Channels (Austin), 2010 Nov-Dec , 4 (475-82).
39. Pubmed Anderson D. et al. Regulation of the KV4.2 complex by CaV3.1 calcium channels. Channels (Austin), 2010 May-Jun , 4 (163-7).
38. Pubmed Bae J. et al. Interaction of T-type calcium channel Ca(V)3.3 with the β-subunit. Mol. Cells, 2010 Sep , 30 (185-91).
37. Pubmed Nikitina E. et al. Alteration in voltage-dependent calcium channels in dog basilar artery after subarachnoid hemorrhage. Laboratory investigation. J. Neurosurg., 2010 Oct , 113 (870-80).
36. Pubmed Kraus R. et al. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice. J. Pharmacol. Exp. Ther., 2010 Nov , 335 (409-17).
35. Pubmed Strege P. et al. T-type Ca(2+) channel modulation by otilonium bromide. Am. J. Physiol. Gastrointest. Liver Physiol., 2010 May , 298 (G706-13).
34. Pubmed Johnston J. et al. Synaptic activation of T-type Ca2+ channels via mGluR activation in the primary dendrite of mitral cells. J. Neurophysiol., 2010 May , 103 (2557-69).
33. Pubmed Wen X. et al. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia. Pharmacology, 2010 , 85 (295-300).
32. Pubmed Barbara G. et al. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J. Neurosci., 2009 Oct 21 , 29 (13106-14).
31. Pubmed Bosch M. et al. 17Beta-estradiol regulation of the mRNA expression of T-type calcium channel subunits: role of estrogen receptor alpha and estrogen receptor beta. J. Comp. Neurol., 2009 Jan 20 , 512 (347-58).
30. Pubmed Tao J. et al. Tyrosine kinase-independent inhibition by genistein on spermatogenic T-type calcium channels attenuates mouse sperm motility and acrosome reaction. Cell Calcium, 2009 Feb , 45 (133-43).
29. Pubmed Zhang C. et al. 17Beta-estradiol regulation of T-type calcium channels in gonadotropin-releasing hormone neurons. J. Neurosci., 2009 Aug 26 , 29 (10552-62).
28. Pubmed Inagaki A. et al. The CaV3.1 T-type Ca2+channel contributes to voltage-dependent calcium currents in rat outer hair cells. Brain Res., 2008 Mar 27 , 1201 (68-77).
27. Pubmed Kang H. et al. Distinct contributions of different structural regions to the current kinetics of the Cav3.3 T-type Ca2+ channel. Biochim. Biophys. Acta, 2008 Dec , 1778 (2740-8).
26. Pubmed Chen Y. et al. Site-directed antibodies to low-voltage-activated calcium channel CaV3.3 (alpha1I) subunit also target neural cell adhesion molecule-180. Neuroscience, 2007 Mar 30 , 145 (981-96).
25. Pubmed Blanks A. et al. Characterization of the molecular and electrophysiological properties of the T-type calcium channel in human myometrium. J. Physiol. (Lond.), 2007 Jun 15 , 581 (915-26).
24. Pubmed Hildebrand M. et al. Selective inhibition of Cav3.3 T-type calcium channels by Galphaq/11-coupled muscarinic acetylcholine receptors. J. Biol. Chem., 2007 Jul 20 , 282 (21043-55).
23. Pubmed Traboulsie A. et al. Subunit-specific modulation of T-type calcium channels by zinc. J. Physiol. (Lond.), 2007 Jan 1 , 578 (159-71).
22. Pubmed Sun H. et al. Zn2+ sensitivity of high- and low-voltage activated calcium channels. Biophys. J., 2007 Aug 15 , 93 (1175-83).
21. Pubmed Nordskog B. et al. Diurnal gene expression patterns of T-type calcium channels and their modulation by ethanol. Neuroscience, 2006 Sep 1 , 141 (1365-73).
20. Pubmed Wang J. et al. CACNA1I is not associated with childhood absence epilepsy in the Chinese Han population. Pediatr. Neurol., 2006 Sep , 35 (187-90).
19. Pubmed Avila T. et al. Transforming growth factor-beta1 and bone morphogenetic protein-2 downregulate CaV3.1 channel expression in mouse C2C12 myoblasts. J. Cell. Physiol., 2006 Nov , 209 (448-56).
18. Pubmed Chevalier M. et al. T-type CaV3.3 calcium channels produce spontaneous low-threshold action potentials and intracellular calcium oscillations. Eur. J. Neurosci., 2006 May , 23 (2321-9).
17. Pubmed Park J. et al. Activation of protein kinase C augments T-type Ca2+ channel activity without changing channel surface density. J. Physiol. (Lond.), 2006 Dec 1 , 577 (513-23).
16. Pubmed Hamid J. et al. Determinants of the differential gating properties of Cav3.1 and Cav3.3 T-type channels: a role of domain IV? Neuroscience, 2006 Dec , 143 (717-28).
15. Pubmed Wen X. et al. Intrathecal administration of Cav3.2 and Cav3.3 antisense oligonucleotide reverses tactile allodynia and thermal hyperalgesia in rats following chronic compression of dorsal root of ganglion. Acta Pharmacol. Sin., 2006 Dec , 27 (1547-52).
14. Pubmed Perez-Reyes E. et al. Molecular biology of T-type calcium channels. CNS Neurol Disord Drug Targets, 2006 Dec , 5 (605-9).
13. Pubmed Perez-Reyes E. et al. Molecular characterization of T-type calcium channels. Cell Calcium, 2006 Aug , 40 (89-96).
12. Pubmed Lory P. et al. T-type calcium channels in differentiation and proliferation. Cell Calcium, 2006 Aug , 40 (135-46).
11. Pubmed Chemin J. et al. Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones. Cell Calcium, 2006 Aug , 40 (121-34).
10. Pubmed Bourinet E. et al. Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J., 2005 Jan 26 , 24 (315-24).
9. Pubmed Park J. et al. Multiple structural elements contribute to the slow kinetics of the Cav3.3 T-type channel. J. Biol. Chem., 2004 May 21 , 279 (21707-13).
8. Pubmed Mudado M. et al. CaV 3.1 and CaV 3.3 account for T-type Ca2+ current in GH3 cells. Braz. J. Med. Biol. Res., 2004 Jun , 37 (929-35).
7. Pubmed Murbartián J. et al. Functional impact of alternative splicing of human T-type Cav3.3 calcium channels. J. Neurophysiol., 2004 Dec , 92 (3399-407).
6. Pubmed Yunker A. et al. Modulation and pharmacology of low voltage-activated ("T-Type") calcium channels. J. Bioenerg. Biomembr., 2003 Dec , 35 (577-98).
5. Pubmed Yunker A. et al. Immunological characterization of T-type voltage-dependent calcium channel CaV3.1 (alpha 1G) and CaV3.3 (alpha 1I) isoforms reveal differences in their localization, expression, and neural development. Neuroscience, 2003 , 117 (321-35).
4. Pubmed Chemin J. et al. [Functional specificity of T-type calcium channels and their roles in neuronal differentiation] J. Soc. Biol., 2003 , 197 (235-47).
3. Pubmed Zhang Y. et al. Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons. J. Neurosci., 2002 Aug 1 , 22 (6362-71).
2. Pubmed Chemin J. et al. The alpha1I T-type calcium channel exhibits faster gating properties when overexpressed in neuroblastoma/glioma NG 108-15 cells. Eur. J. Neurosci., 2001 Nov , 14 (1678-86).
1. Pubmed Mittman S. et al. Structure and alternative splicing of the gene encoding alpha1I, a human brain T calcium channel alpha1 subunit. Neurosci. Lett., 1999 Jul 16 , 269 (121-4).